Summit on Preventing Pharmaceutical Waste

573 views

Published on

Published in: Business, Technology
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
573
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Summit on Preventing Pharmaceutical Waste

  1. 1. National Summit on Preventing Pharmaceutical Waste <br />October 19, 2010<br />University of the Sciences <br />Philadelphia, Pennsylvania <br />1<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />
  2. 2. Who is PSI?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />2<br /><ul><li> Non-profit founded in 2000</li></ul> Membership<br /><ul><li> 46 States
  3. 3. 170+ Local governments
  4. 4. 55+ Corporate, Organizational, Academic </li></ul> Partners<br /><ul><li>Board of Directors: 7 states, 4 local agencies </li></ul>Multi-stakeholder product stewardship network<br />
  5. 5. What is Product Stewardship?<br />“Product Stewardship" is a principle that directs all those involved in the life cycle of a product to take shared responsibility for reducing the health and environmental impacts that result from the production, use, and end-of-life management of the product.<br />
  6. 6. Pharmaceuticals Initiative<br />National Dialogue Meeting #1 – June 2008<br />National Dialogue Meeting #2 – Dec 2008<br />Suggestion for a summit on waste reduction<br />SR Workgroup at the time: organizations, pharmaceutical companies, EPA, state gov’t<br />Workgroup focused on Controlled Substances Act change<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />4<br />
  7. 7. “Source Reduction” Focus<br />Qualitative research under Dr. Becker’s study<br />Florida Department of Environmental Protection<br />Workgroup helped to develop agenda<br />Partnership with WHEN on developing educational modules also under EPA Region 3 project<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />5<br />
  8. 8. PSI’s Role<br />Creating a forum & facilitating discussion<br />Listening for potential action items, policy ideas<br />Summarize what we hear at the meeting<br />Circulate for review<br />Next steps?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />6<br />
  9. 9. Participants’ Role<br />Ask questions<br />Share information/perspectives<br />Think outside the box<br />Be specific<br />Multiple contexts represented<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />7<br />
  10. 10. Agenda:<br />8<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />
  11. 11. Goal<br />Develop public and corporate policy recommendations to reduce the quantity of pharmaceuticals that are no longer wanted or needed in homes and healthcare facilities.<br />We seek to build on information and policy ideas from around the country and from different perspectives. <br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />9<br />
  12. 12. Focus of this Meeting<br />Preventing waste by reducing the quantity of drugs that are no longer wanted or needed in homes and healthcare facilities. <br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />10<br />This meeting will not address issues associated with drug disposal including mail-back or other take-back programs, incineration, etc.<br />
  13. 13. Challenge<br />Complexity of the “ecosystem”<br />Not “one-size-fits-all”<br />Momentum is towards getting people their medicines as easily and cheaply as possible<br />These are not reasons to avoid developing solutions<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />11<br />
  14. 14. Thank you to our meeting sponsors:<br />U.S. Environmental Protection Agency <br />(Region 3)<br />Purdue Pharma L.P.<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />12<br />
  15. 15. Preventing Waste from Unused Prescriptions<br />Overview of the issue & stakeholder considerations<br />MaineCare initial prescription limitation policy<br />Discussion<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />13<br />
  16. 16. Questions<br />What are the pros and cons of short-cycle dispensing?<br />Initial prescription limitations?<br />Are there specific contexts in which this approach would be easier to implement?<br />Voluntary? Mandated?<br />What would need to happen for this to be widely adopted (if that’s what we want)?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />14<br />
  17. 17. Questions<br />Should it apply to all medicines? <br />Only those with higher discontinuation rates?<br />Only those most likely to be abused?<br />To what extent does this depend on the context?<br />What are the options for pro-rating co-pays?<br />What would be the best possible scenario?<br />Are there any next steps on this topic?<br />Other information?<br />Other stakeholders?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />15<br />
  18. 18. Thank you to our meeting sponsors:<br />U.S. Environmental Protection Agency <br />(Region 3)<br />Purdue Pharma L.P.<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />16<br />
  19. 19. Samples/Vouchers: Questions<br />How can we minimize clinic sample waste?<br />How can we encourage the use of vouchers in place of samples?<br />What are the pros and cons?<br />How/can this work in other contexts?<br />Voluntary? Mandated?<br />What would need to happen for this to be widely adopted (if that’s what we want)?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />17<br />
  20. 20. Thank you to our meeting sponsors:<br />U.S. Environmental Protection Agency <br />(Region 3)<br />Purdue Pharma L.P.<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />18<br />
  21. 21. One more time…<br />What are the pros and cons?<br />Are there specific contexts in which this approach would be easier to implement?<br />Voluntary? Mandated?<br />What would need to happen for this to be widely adopted (if that’s what we want)?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />19<br />
  22. 22. Next steps?<br />Additional information?<br />Strategies?<br />People?<br />Forums?<br />October 19, 2010<br />Prepared by the Product Stewardship Institute<br />20<br />

×